LABORATORIO Fundamentals

<div class='circular--portrait' style='background:#347AFC;color: #ffffff;font-size:4em;padding-top: 25px;;'>LR</div>
LABORATORIO REIG fundamental analysis lookup allows you to check this and other indicators for LABORATORIO REIG JOFRE or any other equity instrument. You can also select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please continue to Equity Screeners to view more equity screening tools

Search Fundamentals

 
Refresh

LABORATORIO Revenue Analysis

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and is an essential item when evaluating financial statements of a company. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Revenue 
 = 
Money Received 
Discounts and Returns 
More About Revenue | All Equity Analysis

Current LABORATORIO REIG JOFRE Revenue

187.94 M

About Revenue

Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can includes product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.Compare to competition
Based on latest financial disclosure LABORATORIO REIG JOFRE reported 187.94 M of revenue. This is 97.54% lower than that of the Healthcare sector, and 92.04% lower than that of Drug Manufacturers - Specialty & Generic industry, The Revenue for all stocks is 98.01% higher than the company.

LABORATORIO REIG JOFRE Fundamental Drivers Relationships

LABORATORIO REIG JOFRE is currently regarded number one company in total debt category among related companies. It is currently regarded as top stock in return on asset category among related companies . The ratio of Total Debt to Return On Asset for LABORATORIO REIG JOFRE is about  16,949,153 

Did you try this?

Run Financial Widgets Now

   

Financial Widgets

Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
All  Next Launch Module

LABORATORIO Fundamentals

About LABORATORIO REIG Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze LABORATORIO REIG JOFRE's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LABORATORIO REIG using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LABORATORIO REIG JOFRE based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way. Please read more on our fundamental analysis page.

Current Sentiment - RJF

LABORATORIO REIG JOFRE Investor Sentiment

Macroaxis portfolio users are evenly split in their perspective on investing in LABORATORIO REIG JOFRE. What is your trading attitude regarding investing in LABORATORIO REIG JOFRE? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish
Skip

Currently Active Assets on Macroaxis

NVDA   
Purchased over 40 shares of
1 hour ago
Traded for 1.0
XOM   
Purchased over 200 shares of
1 hour ago
Traded for 1.0
TLRY   
Purchased over 500 shares of
1 hour ago
Traded for 1.0
UCO   
Purchased over 200 shares of
1 hour ago
Traded for 1.0
CRON   
Purchased over 100 shares of
1 hour ago
Traded for 1.0
Additionally, take a look at Your Equity Center. Please also try Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..


 
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page